Brains are constantly flooded with sensory information that needs to be filtered at the pre-
attentional level and integrated into endogenous activity in order to allow for detection of …

The lack of efficacy for antipsychotics with respect to negative symptoms and cognitive
deficits is a significant obstacle for the treatment of schizophrenia. Developing new drugs to …

Schizophrenia represents a pervasive deficit in brain function, leading to hallucinations and
delusions, social withdrawal and a decline in cognitive performance. As the underlying …

Ketamine, an N-methyl-d-aspartate (NMDA) receptor glutamatergic antagonist, has been
studied as a model of schizophrenia when applied in subanesthetic doses. In EEG studies …

The neurotransmitter glutamate is the primary excitatory neurotransmitter in mammalian
brain and is responsible for most corticocortical and corticofugal neurotransmission …

Background: People with schizophrenia exhibit reduced ability to detect change in the
auditory environment, which has been linked to abnormalities in N-methyl-D-aspartate …

The current study analyzed the acute, chronic, and lasting effects of ketamine administration
in four inbred mouse strains (C3H/HeHsd, C57BL/6Hsd, FVB/Hsd, and DBA/2Hsd) to …

Autism is a disabling neurodevelopmental disorder characterized by social deficits,
language impairment, and repetitive behaviors with few effective treatments. New evidence …

To study the neurophysiology of large-scale spatial cognition, we analyzed the neuronal
activity of navigating homing pigeons. This is not possible using conventional radio …

Schizophrenia may well represent one of the most heterogenous mental disorders in human
history. This heterogeneity encompasses (1) etiology; where numerous putative genetic and …